News & Views
Partnership to Develop Immunoassays for Life Science Research
Feb 27 2015
Abcam plc, a global leader in the supply of life science research tools, has signed a partnership agreement with the Institute of Molecular and Cell Biology (IMCB), a research institute under the Agency for Science, Technology and Research (A*STAR), Singapore. Under the terms of the agreement, Abcam will develop a range of RabMAb® antibody pairs against targets jointly selected by IMCB and Abcam. This will include antibody pairs to some of the most important targets in cytokine research which are expected to be available later this year.
“We’re excited about the opportunities that this collaboration will bring to life scientists,” said Alan Hirzel, CEO, Abcam. “By continuing to establish important collaborations, we have the chance to extend our reach to new areas of research. IMCB’s unique R&D capabilities put us in an excellent position to quickly bring innovative immunoassays to global life science researchers, to accelerate the pace of scientific discoveries.”
Professor Wanjin Hong, Executive Director of IMCB, said: “We’re delighted to have signed this agreement. The collaboration will enable IMCB to use Abcam’s proven RabMAb technology and apply it in our R&D programs to advance future development and adoption of immunoassays in immunodiagnostics and therapeutics. In view of the significant R&D expertise and growing importance of the biologics industry in Singapore, this collaboration will help drive antibody discovery and development activities in the region. I am confident that A*STAR and the scientific community will benefit from this promising partnership.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK